These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4828627)

  • 1. Comparison of serum levels of two sustained-release preparations of lithium carbonate.
    Shaw DM; Hewland R; Johnson AL; Hilary-Jones P; Howlett MR
    Curr Med Res Opin; 1974; 2(2):90-4. PubMed ID: 4828627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum lithium levels after slow-release and regular tablets of lithium carbonate].
    Kauko K; Viukari M
    Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of plasma lithium levels and their interindividual variations with coated lithium carbonate tablets and a medium-slow-release lithium sulphate preparation (Lithionit Duretter).
    Persson G
    Acta Psychiatr Scand; 1977 Feb; 55(2):147-52. PubMed ID: 320831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (Lithium lipett C) and lithium carbonate tablets.
    Persson G
    Acta Psychiatr Scand; 1974; 50(2):174-82. PubMed ID: 4853671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of dosage schedules for delayed-action lithium carbonate].
    Balon R; Kabesh Ia
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of side effects with coated lithium carbonate tablets and lithium sulphate preparations giving medium-slow and slow-release.
    Edström A; Persson G
    Acta Psychiatr Scand; 1977 Feb; 55(2):153-8. PubMed ID: 320832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the excretion curves of 2 lithium salt preparations: carbonate slow-release sulfate (pharmacological and statistical study)].
    Rutigliano G; Chieppa M; Leonetti S
    Acta Neurol (Napoli); 1974; 29(1):77-92. PubMed ID: 4828165
    [No Abstract]   [Full Text] [Related]  

  • 8. Lithium absorption from ordinary and from sustained-release tablets.
    Otto U; Paalzow L; Surén G
    Acta Pharm Suec; 1972 Dec; 9(6):595-601. PubMed ID: 4656566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience in the treatment of manic-depressive states with orally administered enteric-coated lithium carbonate tablets].
    Ishida M; Orihashi Y; Igarashi A; Kakita Y; Takeuchi A
    Iryo; 1972 Mar; 26(3):229-37. PubMed ID: 5027291
    [No Abstract]   [Full Text] [Related]  

  • 10. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
    Ciftçi K; Capan Y; Oztürk O; Hincal AA
    Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical administration of lithiumaspartate].
    Consbruch U; Orth M; Degkwitz R
    Arzneimittelforschung; 1974 Aug; 24(8):1077-9. PubMed ID: 4479527
    [No Abstract]   [Full Text] [Related]  

  • 12. The 24-hour serum lithium level as a prognosticator of dosage requirements.
    Cooper TB; Bergner PE; Simpson GM
    Am J Psychiatry; 1973 May; 130(5):601-3. PubMed ID: 4699934
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
    Caldwell HC; Westlake WJ; Connor SM; Flanagan T
    J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of lithium carbonate.
    Blinder MG
    Behav Neuropsychiatry; 1972; 4(3-4):22-4. PubMed ID: 4672283
    [No Abstract]   [Full Text] [Related]  

  • 15. Repeated sustained-release lithium carbonate administration to cats.
    Marini JL; Williams SP; Sheard MH
    Toxicol Appl Pharmacol; 1978 Mar; 43(3):559-67. PubMed ID: 653727
    [No Abstract]   [Full Text] [Related]  

  • 16. Slow-release lithium carbonate.
    Coppen A; Bailey JE; White SG
    J Clin Pharmacol J New Drugs; 1969; 9(3):160-2. PubMed ID: 5255180
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability of lithium carbonate and lithium citrate: a comparison of two controlled-release preparations.
    Tyrer SP; Peat MA; Minty PS; Luchini A; Glud V; Amdisen A
    Pharmatherapeutica; 1982; 3(4):243-6. PubMed ID: 6815664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of assay methodology on the prediction of lithium maintenance dosage.
    Karki SD; Carson SW; Holden JM
    DICP; 1989 May; 23(5):372-5. PubMed ID: 2728523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).
    Bennie EH; Manzoor AK; Scott AM; Fell GS
    Br J Clin Pharmacol; 1977 Aug; 4(4):479-83. PubMed ID: 901741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspect of the pharmacokinetics of slow-release lithium carbonate.
    Hart GA
    S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.